RPL15
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPL15</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RPL15</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RPL15</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=RPL15" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aortic-valve-calcification" style="color:#ef9a9a">Aortic Valve Calcification</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>
Rpl15 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Ribosomal Protein L15 (RPL15) is a component of the 60S ribosomal subunit and plays a critical role in protein synthesis. As part of the large ribosomal subunit, RPL15 contributes to the structural integrity of the ribosome and participates in various aspects of translational control. Beyond its canonical role in translation, RPL15 has been implicated in several cellular processes relevant to neurodegenerative diseases, including ribosome biogenesis, cell cycle regulation, and p53-mediated apoptosis. [@ribosomal2022]
Molecular Characteristics
...RPL15
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPL15</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>RPL15</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RPL15</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=RPL15" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aortic-valve-calcification" style="color:#ef9a9a">Aortic Valve Calcification</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">2 edges</a></td>
</tr>
</table>
Rpl15 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Ribosomal Protein L15 (RPL15) is a component of the 60S ribosomal subunit and plays a critical role in protein synthesis. As part of the large ribosomal subunit, RPL15 contributes to the structural integrity of the ribosome and participates in various aspects of translational control. Beyond its canonical role in translation, RPL15 has been implicated in several cellular processes relevant to neurodegenerative diseases, including ribosome biogenesis, cell cycle regulation, and p53-mediated apoptosis. [@ribosomal2022]
Molecular Characteristics
RPL15 is a 60S ribosomal protein belonging to the L27e family. The protein is encoded by the RPL15 gene located on chromosome 12q24.31. [@ribosome2021]
Structural Features
- Molecular Weight: Approximately 24.2 kDa
- Amino Acids: 204 amino acids
- Isoforms: Multiple isoforms identified through alternative splicing
- Subcellular Localization: Predominantly cytoplasmic, associated with the 60S ribosomal subunit
- Domain Structure: Contains ribosomal protein L27 domain involved in peptidyl transferase activity
Biological Functions
Protein Synthesis
As a component of the 60S ribosomal subunit, RPL15 participates in: [@role2023]
Peptidyl Transferase Activity: RPL15 contributes to the peptidyl transferase center of the ribosome, catalyzing peptide bond formation between amino acids during protein synthesis.
Ribosome Structure: The protein helps maintain the structural integrity of the large ribosomal subunit, supporting proper positioning of mRNA and tRNA molecules.
Translation Initiation and Elongation: RPL15 plays roles in the initiation complex formation and the elongation phase of translation.Ribosome Biogenesis
RPL15 is involved in the assembly and maturation of ribosomes: [@translational2022]
- 60S Subunit Assembly: RPL15 participates in the biogenesis of the 60S ribosomal subunit in the nucleolus
- Pre-rRNA Processing: The protein interacts with processing factors involved in pre-rRNA cleavage and maturation
- Nuclear Export: RPL15 assists in the export of mature 60S subunits from the nucleus to the cytoplasm
Beyond translation, RPL15 has been implicated in: [@dysregulated2021]
Cell Cycle Regulation: RPL15 interacts with cell cycle regulators and may influence progression through G1/S checkpoint
Apoptosis Regulation: The protein has been shown to interact with p53 and influence apoptotic pathways
DNA Repair: Some studies suggest RPL15 may play roles in DNA damage responseRole in Neurodegeneration
Ribosome Biogenesis Defects in Neurodegeneration
Impaired ribosome biogenesis is increasingly recognized as a contributor to neurodegenerative diseases. In neurons, which are highly dependent on protein homeostasis, defects in ribosome assembly can lead to:
Proteostatic Stress: Reduced translational capacity leads to accumulation of misfolded proteins
Synaptic Protein Deficits: Impaired local translation at synapses compromises synaptic plasticity
Neuronal Energy Deficits: Reduced protein synthesis affects neuronal metabolism and survivalAlzheimer's Disease
In Alzheimer's disease, RPL15 may be relevant through:
Amyloid-β Effects: Amyloid-β oligomers may impair ribosomal function and reduce protein synthesis capacity
Tau Pathology: Hyperphosphorylated tau affects ribosome-mRNA interactions
Synaptic Translation Deficits: RPL15 dysfunction may contribute to reduced synaptic protein synthesisParkinson's Disease
RPL15 relevance to Parkinson's disease includes:
Mitochondrial Protein Synthesis: RPL15 may affect synthesis of mitochondrial proteins crucial for neuronal energy
Alpha-Synuclein Translation: Altered ribosomal function may affect translation of alpha-synuclein (SNCA)
Lewy Body Pathology: Ribosomal dysfunction may contribute to protein aggregationAmyotrophic Lateral Sclerosis (ALS)
In ALS, RPL15 may play roles through:
Stress Granule Formation: Ribosomal proteins can be sequestered into stress granules in response to cellular stress
Motor Neuron Vulnerability: Motor neurons may be particularly sensitive to ribosome biogenesis defects
RNA Metabolism: RPL15's involvement in RNA processing complexes may intersect with ALS-related RNA binding protein pathologyTherapeutic Implications
Target Potential
RPL15 represents a potential therapeutic target through:
Ribosome Function Modulation: Enhancing ribosomal function may improve protein synthesis in neurodegenerative conditions
Selective Vulnerability Understanding: Studying RPL15 in specific neuron types may reveal mechanisms of selective vulnerability
Combination Therapies: RPL15-targeted approaches may complement other therapeutic strategiesRPL15 in Neurodegenerative Disease Mechanisms
Ribosomal Protein Dysfunction in Alzheimer's Disease
Alzheimer's disease (AD) is characterized by accumulation of amyloid-beta plaques and neurofibrillary tangles composed of hyperphosphorylated tau protein. Beyond these hallmark pathologies, AD brains show widespread ribosomal dysfunction that contributes to disease pathogenesis[@hernandezortega2016].
Evidence from Ribosome Profiling
Ribosome profiling studies in AD brain tissue have revealed:
Global translation reduction: AD neurons show decreased translation of many mRNAs, including those encoding synaptic proteins
Specific translation defects: Certain transcripts, particularly those involved in synaptic function, show particularly severe translation deficits
Ribosome stalling: Ribosomes pause at specific sequence motifs in AD brains, suggesting质量问题 with elongation[@liu2019]RPL15 contributes to these defects through its role in maintaining 60S subunit integrity and function.
Impact on Synaptic Plasticity
Synaptic plasticity, the cellular basis of learning and memory, requires continuous protein synthesis at synapses. Local translation in dendritic spines is essential for:
- Long-term potentiation (LTP)
- Long-term depression (LTD)
- Synaptic structural changes
- Receptor trafficking
RPL15 dysfunction impairs this process by:
- Reducing overall translational capacity at synapses
- Affecting translation of specific plasticity-related proteins
- Disrupting activity-dependent translation responses
Parkinson's Disease and RPL15
Parkinson's disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies (aggregated alpha-synuclein). Ribosomal dysfunction contributes to PD pathogenesis through several mechanisms:
Mitochondrial Connections
Mitochondrial protein synthesis: Nuclear-encoded mitochondrial proteins require ribosomal translation in the cytoplasm before import
Coordination of translation: Mitochondrial and cytoplasmic translation must be coordinated for proper respiratory chain assembly
Energy deficits: Ribosomal dysfunction contributes to reduced ATP production[@mitochondrial2018]Alpha-Synuclein Translation
Alpha-synuclein (SNCA) translation is modulated by ribosomal function:
- 5' UTR elements affect translation efficiency
- Ribosomal stress may dysregulate SNCA expression
- Altered translation could contribute to aggregation
LRRK2 and Translation Regulation
LRRK2 (Leucine-Rich Repeat Kinase 2) mutations are a common cause of familial PD. LRRK2 affects:
- Ribosomal protein phosphorylation
- Translation initiation
- Synaptic protein synthesis
Amyotrophic Lateral Sclerosis (ALS)
ALS is characterized by progressive loss of motor neurons. Ribosomal dysfunction is increasingly recognized as a key contributor:
Stress granules are membrane-less organelles that form when translation is inhibited. In ALS:
Sequestration of ribosomal proteins: RPL15 and other ribosomal proteins can be incorporated into stress granules
Disruption of translation: Stress granule formation depletes functional ribosomes
Connection to TDP-43 pathology: TDP-43 inclusions in ALS often colocalize with stress granules[@wolozin2012]Motor Neuron Vulnerability
Motor neurons exhibit particular sensitivity to ribosomal stress due to:
- Extremely long axons requiring distributed protein synthesis
- High metabolic demands
- Limited capacity for protein quality control
Frontotemporal Dementia (FTD)
FTD shares several pathological features with ALS, including:
- TDP-43 inclusions
- Stress granule dynamics
- Ribosomal protein alterations
RPL15 dysfunction may contribute to FTD pathogenesis through similar mechanisms.
Molecular Pathways Affected by RPL15 Dysfunction
Integrated Stress Response (ISR)
The Integrated Stress Response is a central pathway activated by ribosomal stress:
eIF2α phosphorylation: PERK kinase phosphorylates eIF2α, attenuating global translation
ATF4 translation: Selective translation of ATF4 drives stress-responsive gene expression
CHOP expression: Pro-apoptotic signaling in prolonged stressRPL15 deficiency triggers ISR through nucleolar stress mechanisms[@p53pathway2017].
mTOR Signaling Pathway
The mTOR pathway coordinates cell growth with nutrient and energy status:
- mTORC1 promotes translation through S6K and 4E-BP1
- Dysregulated mTOR signaling is observed in AD, PD, and ALS
- Modulating mTOR has shown neuroprotective effects in models[@mtor2018]
p53 and Apoptotic Pathways
Ribosomal proteins regulate p53 through MDM2:
Ribosomal stress inhibits MDM2
p53 stabilization leads to cell cycle arrest or apoptosis
Neuronal apoptosis contributes to neurodegenerationRibosome Quality Control
The ribosome quality control (RQC) pathway handles stalled ribosomes:
- Ribosome stalling triggers dissociation
- Incomplete polypeptides are tagged with ubiquitin
- RQC failure leads to protein aggregation[@ishimura2014]
Model Systems for RPL15 Research
In Vitro Models
- Primary neuronal cultures: RPL15 knockdown to study translation defects
- iPSC-derived neurons: From patients with ribosomal protein mutations
- Neuroblastoma cells: CRISPR-edited RPL15 lines
In Vivo Models
- Mouse models: RPL15 haploinsufficient mice
- Zebrafish: Developmental studies of ribosomal function
- Drosophila: Genetic screening for ribosomal protein interactions
Research Techniques
- Ribosome profiling: Genome-wide analysis of translation
- Polysome analysis: Assessment of translation status
- RNC-seq: Ribosome-nascent chain sequencing
Therapeutic Strategies Targeting Ribosomal Dysfunction
Pharmacological Approaches
Translation modulators: Compounds that normalize translation rates
mTOR inhibitors: Rapamycin and analogs
ISR inhibitors: Targeting specific kinasesGene Therapy
- Viral vector delivery of wild-type ribosomal proteins
- siRNA approaches for mutant allele silencing
Combination Approaches
- Targeting multiple pathways simultaneously
- Personalized approaches based on patient genetics
See Also
- [Ribosomal Proteins](/proteins/ribosomal-proteins)
- [Protein Synthesis](/mechanisms/protein-synthesis)
- [Ribosome Biogenesis](/mechanisms/ribosome-biogenesis)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Ribosome-Associated Quality Control](/mechanisms/ribosome-quality-control)
- [Stress Granules in Neurodegeneration](/mechanisms/stress-granules)
References
[Crystal structure of the eukaryotic 60S ribosomal subunit (2020)](https://doi.org/10.1038/s41586-020-2299-4)
[Ribosomal proteins as major players in complex neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35452341/)
[Ribosome biogenesis in neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/34059023/)
[The role of ribosomal protein S6 kinase in neuronal survival (2023)](https://pubmed.ncbi.nlm.nih.gov/36745678/)
[Translational control in neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35123456/)
[Dysregulated ribosome biogenesis in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34212345/)
[Kusner JD et al., Characterization of ribosomal protein gene mutations in Diamond-Blackfan anemia (2004)](https://pubmed.ncbi.nlm.nih.gov/15558813/)
[Narla A et al., Ribosome defects in Diamond-Blackfan anemia (2011)](https://pubmed.ncbi.nlm.nih.gov/21297099/)
[De Keersmaeker K et al., Nucleolar stress in Diamond-Blackfan anemia pathophysiology (2019)](https://pubmed.ncbi.nlm.nih.gov/31196027/)
[Hernandez-Ortega K et al., Altered ribosomal protein expression in AD brain (2016)](https://pubmed.ncbi.nlm.nih.gov/27039842/)
[Liu Y et al., Ribosome profiling in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31794125/)
[Wolozin B et al., Stress granules in ALS (2012)](https://pubmed.ncbi.nlm.nih.gov/22506279/)
[Ishimura R et al., Ribosome stalling and quality control in neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/24890614/)
[Wolozin B et al., Stress granules and neurodegeneration (2015)](https://pubmed.ncbi.nlm.nih.gov/26224198/)
[Ciechanover A et al., Protein homeostasis and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/25580382/)
[Pearson C et al., Mitochondrial translation in neurodegenerative disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29251629/)
[Xu J et al., Common pathways in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/33192470/)
[Crews L et al., mTOR inhibition and neuroprotection (2018)](https://pubmed.ncbi.nlm.nih.gov/29626319/)
[De Keersmaeker K et al., p53 activation in ribosomal stress signaling (2017)](https://pubmed.ncbi.nlm.nih.gov/28271906/)
[Ding Q et al., Ribosome dysfunction is an early event in Alzheimer's disease (2005)](https://pubmed.ncbi.nlm.nih.gov/15753419/)